Pathstone Holdings »

Athira Pharma shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Athira Pharma shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $160k 39k 4.14

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma